Bionano reports Q2 revenue, raises guidance
Bionano Genomics said Q2 2026 revenue was $8.2 million, raised FY26 guidance and gave a FY27 revenue target. It also projected EBITDA break-even in Q4 FY27.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bionano Genomics said Q2 2026 revenue was $8.2 million, raised FY26 guidance and gave a FY27 revenue target. It also projected EBITDA break-even in Q4 FY27.